A review of postlysis strategy.
The postthrombolysis potential for rethrombosis, unstable angina, and reinfarction is considered, as is adjunctive pharmacologic treatment that may reduce the incidence of such complications.
Roberts
R
R
Bugher Foundation center for Molecular Biology, Baylor College of Medicine, Houston, Texas.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D012008:Recurrence
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents